The Barcelona
Blood-Brain-Barrier (B4)

21 - 22 may 2024 · Parc Científic de Barcelona


21 - 22 may 2024 · Parc Científic de Barcelona

The Barcelona
Blood-Brain-Barrier (B4)

Building Networks, Overcoming Barriers

To fulfil the promise of applying bioengineering to improve the lives of patients, we need to adopt a holistic approach encompassing understanding of biological/pathological mechanisms, development of engineered systems, and consideration of clinical needs. Hence, the B4 symposium, by bringing together experts studying the BBB from a biological, engineering and medical perspective, will greatly aid IBEC in its goal of developing bioengineering solutions to deliver therapies against brain disorders. 

Barcelona is home to numerous research groups pushing forward the knowledge frontier of the blood-brain barrier (BBB) and its role in brain disorders. To foment interaction across this community, we are organizing the Barcelona Blood-Brain-Barrier (B4) symposium to bring the BBB-community of Barcelona together to discuss advances in the field. The event will focus on the mechanisms underlying BBB physiology (e.g., brain endothelial specialization, neurovascular coupling, molecular transport), its role in brain disorders (neurodegeneration, infectious diseases, cancer), and nano/bioengineering strategies to deliver therapies across the BBB.

The first edition of this symposium will take place on May 21st-22nd, 2024. As our inaugural keynote speaker, we have the honour to welcome Prof. Martin Lauritzen (Copenhagen University). Prof. Lauritzen has been instrumental in our understanding of regulation of cerebral blood-flow by the neurovascular unit, nanoparticle transport dynamics across the BBB, and in developing in vivo imaging systems to study the brain vasculature.


Abstract submission: 15/04/2024 30/04/2024
Notification of acceptance: Beginning May 
Registration: 14/05/2024

Conference cancellation policy



keynote speakers:

Martin Lauritzen, University of Copenhagen

Roberto Villasenor Solorio, Roche- Pharma Research and Early Development (pRED)


Giuseppe Battaglia, Institute for Bioengineering of Catalonia (IBEC)

Maria Bernabeu Aznar, European Molecular Biology Laboratory (EMBL), Barcelona

Giancarlo Franzese, Department of Condensed Matter Phycics, University of Barcelona

Angeles Garcia Cazorla, Hospital Sant Joan de Deu 

Ana Lagunas Targarona, Institute for Bioengineering of Catalonia (IBEC)

Kostas Kostarelos, Catalan Institute of Nanoscience and Nanotechnology (ICN2)

Benjamin Oller Salvia, Institute de Quimica de Sarria (IQS), Universitat Ramon Llull

Anna Planas, Instituto de Investigaciones Biomedicas de Barcelona (IibB), CSIC

Anna Rosell Novel, Vall d’Hebron Research Institute

Josep Samitier, Institute for Bioengineering of Catalonia (IBEC)

Simo Schwartz, Vall d’Hebron Hospital

Tom Kisby, Centre for Nanotechnology in Medicine, Manchester University, U.K.


Organized by:


Auditori Antoni Caparrós
Parc Científic de Barcelona
C. Bardiri Reixac, 4-8, Barcelona

abstracts submision:

Please use this template to submit your abstract.



Registrations cancelled before 20th April 2024 are eligible for a refund of the registration fees paid, except from 20€ related to administration costs incurred.

Registrations cancelled after 20th April 2024 are no longer eligible for a refund.